Breye Therapeutics
H├╕rsholm
About Breye Therapeutics
Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.1M
- Funding stage: Seed
- Last round: Seed (Nov 2022)
- Website: breyetx.com
Industries & Categories
Biopharma, Medical
Canonical: https://fsome.com/organization/breye-therapeutics-57401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.